Pingjiao Gu, Yang Yang, Jipeng Shi, Weiji Li, Qiaoyi Shao, Yiheng Dai
{"title":"Gestational age-specific metabolic biomarkers for early prediction of bronchopulmonary dysplasia following standardized enteral feeding.","authors":"Pingjiao Gu, Yang Yang, Jipeng Shi, Weiji Li, Qiaoyi Shao, Yiheng Dai","doi":"10.1038/s41372-026-02850-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Early prediction of Bronchopulmonary dysplasia (BPD) remains challenging. Utilizing the NRN 2019 definition and a standardized feeding protocol, this study aimed to identify gestational age (GA)-specific metabolic signatures to optimize early prediction.</p><p><strong>Methods: </strong>This retrospective study enrolled 455 preterm infants (GA < 32 weeks). Dried blood spots collected at ~14 days postnatal age following standardized nutritional management were analyzed for 83 metabolites via LC-MS/MS to construct GA-stratified predictive models.</p><p><strong>Results: </strong>Distinct GA-specific metabolic signatures involving specific amino acid and acylcarnitine alterations were identified. Incorporating these biomarkers significantly improved predictive models compared to baseline clinical models: the AUC increased from 0.765 to 0.852 in the GA < 28 weeks subgroup, and from 0.629 to 0.707 in the GA 28-31<sup>+6</sup> weeks subgroup (both P < 0.05).</p><p><strong>Conclusions: </strong>Post-standardized feeding metabolic profiling at 2 weeks captures distinct GA-specific alterations. Integrating these biomarkers with NRN 2019 criteria significantly enhances early BPD prediction, offering clinical utility for targeted risk stratification.</p>","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Perinatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41372-026-02850-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Early prediction of Bronchopulmonary dysplasia (BPD) remains challenging. Utilizing the NRN 2019 definition and a standardized feeding protocol, this study aimed to identify gestational age (GA)-specific metabolic signatures to optimize early prediction.
Methods: This retrospective study enrolled 455 preterm infants (GA < 32 weeks). Dried blood spots collected at ~14 days postnatal age following standardized nutritional management were analyzed for 83 metabolites via LC-MS/MS to construct GA-stratified predictive models.
Results: Distinct GA-specific metabolic signatures involving specific amino acid and acylcarnitine alterations were identified. Incorporating these biomarkers significantly improved predictive models compared to baseline clinical models: the AUC increased from 0.765 to 0.852 in the GA < 28 weeks subgroup, and from 0.629 to 0.707 in the GA 28-31+6 weeks subgroup (both P < 0.05).
Conclusions: Post-standardized feeding metabolic profiling at 2 weeks captures distinct GA-specific alterations. Integrating these biomarkers with NRN 2019 criteria significantly enhances early BPD prediction, offering clinical utility for targeted risk stratification.
期刊介绍:
The Journal of Perinatology provides members of the perinatal/neonatal healthcare team with original information pertinent to improving maternal/fetal and neonatal care. We publish peer-reviewed clinical research articles, state-of-the art reviews, comments, quality improvement reports, and letters to the editor. Articles published in the Journal of Perinatology embrace the full scope of the specialty, including clinical, professional, political, administrative and educational aspects. The Journal also explores legal and ethical issues, neonatal technology and product development.
The Journal’s audience includes all those that participate in perinatal/neonatal care, including, but not limited to neonatologists, perinatologists, perinatal epidemiologists, pediatricians and pediatric subspecialists, surgeons, neonatal and perinatal nurses, respiratory therapists, pharmacists, social workers, dieticians, speech and hearing experts, other allied health professionals, as well as subspecialists who participate in patient care including radiologists, laboratory medicine and pathologists.